Oxford Asset Management’s Medpace MEDP Stock Holding History

Oxford Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-670	Closed	-$224K	–	540
2024 Q3	$224K	Buy	+670	New	+$255K	0.19%	221
2019 Q4	–	Sell	-32,673	Closed	-$2.75M	–	1955
2019 Q3	$2.75M	Buy	32,673 +12,918	+65%	+$976K	0.07%	377
2019 Q2	$1.29M	Buy	+19,755	New	+$1.14M	0.03%	854
2018 Q4	–	Sell	-91,362	Closed	-$5.47M	–	1960
2018 Q3	$5.47M	Sell	91,362 -8,026	-8%	-$439K	0.11%	202
2018 Q2	$4.28M	Buy	99,388 +25,973	+35%	+$1.05M	0.08%	265
2018 Q1	$2.56M	Sell	73,415 -23,663	-24%	-$865K	0.05%	450
2017 Q4	$3.55M	Sell	97,078 -1,527	-2%	-$53.5K	0.08%	319
2017 Q3	$3.13M	Buy	98,605 +17,161	+21%	+$524K	0.06%	387
2017 Q2	$2.36M	Sell	81,444 -787	-1%	-$22.1K	0.05%	526
2017 Q1	$2.46M	Buy	+82,231	New	+$2.65M	0.06%	377

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Oxford Asset Management's MEDP Position: Q4 2024 in Review

Oxford Asset Management sold out of Medpace (MEDP) in Q4 2024, closing a stake of 670 shares — an estimated $224K sold.

Oxford Asset Management first reported a position in MEDP in Q1 2017 and held it in 10 quarters. The position peaked at $5.47M in Q3 2018. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

Oxford Asset Management reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
Oxford Asset Management sold 670 Medpace shares in Q4 2024, an estimated $224K.
Oxford Asset Management first reported a position in Medpace in Q1 2017 and held it in 10 quarters.
Oxford Asset Management's Medpace position peaked at $5.47M in Q3 2018.
592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Oxford Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.